ストックスクリーナーアプリを入手
2.13
7.39%
-0.17
Bioxcel Therapeutics Inc (BTAI) 最新ニュース
BTAI stock plunges to 52-week low of $2.16 amid market challenges - Investing.com Nigeria
BioXcel Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
BioXcel Therapeutics expands board, appoints new director - MSN
BioXcel Therapeutics announces 1-for-16 reverse stock split - MSN
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Short Interest Update - MarketBeat
BTAI stock touches 52-week low at $2.53 amid sharp annual decline - MSN
A significant driver of top-line growth: BioXcel Therapeutics Inc (BTAI) - SETE News
You Should Look At The Stock Forecast For BioXcel Therapeutics Inc (NASDAQ: BTAI). - Marketing Sentinel
BioXcel Therapeutics Inc (BTAI) Shares Down Despite Recent Market Volatility - The News Heater
The Psychology of BioXcel Therapeutics Inc Inc. (BTAI) Price Performance: Understanding Market Sentiment - The InvestChronicle
Balance Sheet Insights: BioXcel Therapeutics Inc (BTAI)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential - Marketscreener.com
BioXcel Therapeutics, Inc. Appoints June Bray to its Board of Directors -March 01, 2021 at 10:13 am EST - Marketscreener.com
BioXcel Therapeutics Announces Appointment of Reina Benabou, M.D., Ph.D., as Senior Vice President and Chief Development Officer - Marketscreener.com
BioXcel Therapeutics Shares Rise Premarket on FDA Fast-Track Designation -February 12, 2024 at 07:43 am EST - Marketscreener.com
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts BioXcel Therapeutics (BTAI) Investors to Pending Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys - ACCESS Newswire
BioXcel Therapeutics enacts 1-for-16 reverse stock split - MSN
BioXcel Therapeutics announces reverse stock split - Hartford Business Journal
BioXcel Therapeutics announces 1-for-16 reverse stock split By Investing.com - Investing.com Nigeria
BioXcel to execute 1-for-16 reverse stock split - MSN
BioXcel to Implement Reverse Stock Split; Shares Fall -February 06, 2025 at 01:28 pm EST - Marketscreener.com
BioXcel Therapeutics Announces Reverse Stock Split - citybiz
BioXcel Therapeutics enacts 1-for-16 reverse stock split By Investing.com - Investing.com Canada
BioXcel Therapeutics Sets 1-for-16 Reverse Stock Split To Regain Nasdaq Listing - Nasdaq
BioXcel's Strategic Reverse Split: Critical Move to Preserve Nasdaq StatusWhat's at Stake - StockTitan
BioXcel Therapeutics advances key clinical trials - Investing.com India
BioXcel Therapeutics Inc (BTAI) Shares Plummet Below 1-Year High - The News Heater
BioXcel Therapeutics advances key clinical trials By Investing.com - Investing.com South Africa
BioXcel Therapeutics Provides Clinical and Business Update -February 05, 2025 at 07:45 am EST - Marketscreener.com
BioXcel Therapeutics Provides Clinical and Business Update - The Manila Times
Clinical Progress Alert: BioXcel's Strategic Moves in Agitation Treatment Trials Gain Momentum - StockTitan
BioXcel Therapeutics, Inc. Provides Clinical and Business Update -February 05, 2025 at 07:00 am EST - Marketscreener.com
Observations on the BioXcel Therapeutics Inc (NASDAQ:BTAI) Growth Curve - US Post News
What is HC Wainwright’s Forecast for BTAI FY2024 Earnings? - Defense World
BioXcel Therapeutics Holds Special Meeting, Approves Reverse Stock Split Plan - Defense World
HC Wainwright Cuts BioXcel Therapeutics (NASDAQ:BTAI) Price Target to $3.00 - Defense World
BioXcel Therapeutics stock hits 52-week low at $0.3 - MSN
BioXcel Therapeutics stock hits 52-week low at $0.3 By Investing.com - Investing.com Australia
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):